Health-related quality of life in long-term survivors of childhood brain tumors. 2009

Tonny Solveig Reimers, and Erik Lykke Mortensen, and Karsten Nysom, and Kjeld Schmiegelow
Department of Psychology, Play Therapy and Social Counselling, The Juliane Marie Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. tonny.reimers@rh.regionh.dk

BACKGROUND To identify predictors for health-related quality of life (HRQOL) in survivors of childhood brain tumors and its relationship to cognitive function. METHODS One hundred twenty-six consecutive Danish childhood brain tumor patients treated 1970-1997 and being 7.9-40.4 years at follow-up were assessed for general intelligence (IQ) and administered the Minneapolis-Manchester Quality of Life (MMQL) questionnaire. RESULTS In multivariate linear regression treatment with RT was the most important risk factor for reduced HRQOL. Lower scores for physical functioning and energy, social functioning, cognitive functioning, body image, outlook of life, and intimate relations were significantly related to RT. Tumor location in the posterior fossa was associated with lower scores for physical functioning and energy, and tumor site in the third ventricle region was associated with lower scores for body image. Younger age at diagnosis was associated with lower scores for social functioning and intimate relations, and younger age at follow-up was associated with more physical symptoms. When IQ was included as a covariate, RT only remained significant for social functioning and intimate relations while tumor location in the third ventricle region remained significant for body image, younger age at diagnosis for social functioning and intimate relations, and younger age at follow-up for physical symptoms. In contrasts, neither gender nor presence of hydrocephalus requiring shunt inserted predicted significantly reduced HRQOL in the multivariate analyses. CONCLUSIONS RT is an important predictor of HRQOL primarily due to its effect on general intelligence, which suggests that IQ is a strong determinant of HRQOL.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007360 Intelligence The ability to learn and to deal with new situations and to deal effectively with tasks involving abstractions.
D008297 Male Males
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003718 Denmark A country in northern Europe, bordering the Baltic Sea and the North Sea. The capital is Copenhagen. Faeroe Islands,Faroe Islands

Related Publications

Tonny Solveig Reimers, and Erik Lykke Mortensen, and Karsten Nysom, and Kjeld Schmiegelow
June 2022, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer,
Tonny Solveig Reimers, and Erik Lykke Mortensen, and Karsten Nysom, and Kjeld Schmiegelow
November 2017, Current neurology and neuroscience reports,
Tonny Solveig Reimers, and Erik Lykke Mortensen, and Karsten Nysom, and Kjeld Schmiegelow
July 2015, Journal of pediatric hematology/oncology,
Tonny Solveig Reimers, and Erik Lykke Mortensen, and Karsten Nysom, and Kjeld Schmiegelow
January 2012, PloS one,
Tonny Solveig Reimers, and Erik Lykke Mortensen, and Karsten Nysom, and Kjeld Schmiegelow
July 2015, Psycho-oncology,
Tonny Solveig Reimers, and Erik Lykke Mortensen, and Karsten Nysom, and Kjeld Schmiegelow
December 2021, Pediatric blood & cancer,
Tonny Solveig Reimers, and Erik Lykke Mortensen, and Karsten Nysom, and Kjeld Schmiegelow
April 2023, Neuro-oncology practice,
Tonny Solveig Reimers, and Erik Lykke Mortensen, and Karsten Nysom, and Kjeld Schmiegelow
August 2010, Pediatric blood & cancer,
Tonny Solveig Reimers, and Erik Lykke Mortensen, and Karsten Nysom, and Kjeld Schmiegelow
January 1999, International journal of cancer. Supplement = Journal international du cancer. Supplement,
Tonny Solveig Reimers, and Erik Lykke Mortensen, and Karsten Nysom, and Kjeld Schmiegelow
March 2006, Pediatric blood & cancer,
Copied contents to your clipboard!